Literature DB >> 2806829

Campylobacter pylori in Japan: bacteriological feature and prevalence in healthy subjects and patients with gastroduodenal disorders.

H Inouye1, I Yamamoto, N Tanida, J Mikami, K Tamura, T Ohno, M Kano, T Shimoyama.   

Abstract

The presence of Campylobacter pylori was investigated in biopsy specimens obtained during gastrofiberscopy from 103 consecutive patients prospectively. Patients included 25 with gastric ulcer, 4 with duodenal ulcer, 5 with coexisting gastroduodenal ulcer, 31 with gastroduodenal ulcer with gastritis, 27 with gastritis, 3 with gastric polyps and 8 with gastric cancer. Results were compared with 20 healthy control subjects who were endoscopically normal. Two specimens each were taken from 3 sites in the stomach. One part was used for a histological study to examine the presence of the organisms. The other part was cultured using Skirrow's agar microaerophilically. Conventional microflora and C. pylori were examined in gastric contents of some cases. Bacteriological features of isolated strains of C. pylori were identical to the NCTC strain. C. pylori was the most dominant organism in gastric contents at any pH level. Detection rates of C. pylori by bacteriological culture were 96% in gastric ulcer, 100% in duodenal ulcer, 80% in coexisting gastroduodenal ulcer, 84% in gastroduodenal ulcer with gastritis, 70% in gastritis, 100% in gastric polyps and 100% in gastric cancer, and the percentages recognized by histological studies were 81, 100, 100, 84, 71, 67, and 57%, respectively. The values in healthy controls were 55% by histological and bacteriological methods (P less than 0.001 compared with overall ulcer patients). These results supported the close association between C. pylori and gastroduodenal diseases.

Entities:  

Mesh:

Year:  1989        PMID: 2806829     DOI: 10.1007/bf02773875

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  20 in total

1.  [Relationship between microflora of the upper small intestine and steatorrhoea in patients with extensive gastric resection].

Authors:  K Amano
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1987-08

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Campylobacter-like organisms in the stomach of patients and healthy individuals.

Authors: 
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

4.  [Isolation of Campylobacter pyloridis from gastric mucosa of patients with gastric complaints and susceptibility of the isolates on antibiotics].

Authors:  E Ishii; T Kishi; H Inoue; T Shimoyama; T Tanaka; T Tsuyuguchi; T Tamura; K Shoji
Journal:  Kansenshogaku Zasshi       Date:  1987-06

5.  Campylobacter like organisms on the gastric mucosa: culture, histological, and serological studies.

Authors:  D M Jones; A M Lessells; J Eldridge
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

6.  Naturally occurring chronic gastritis and C pylori infection in the rhesus monkey: a potential model for gastritis in man.

Authors:  A Baskerville; D G Newell
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

7.  Role of bacteria in gastric ulceration produced by indomethacin in the rat: cytoprotective action of antibiotics.

Authors:  H Satoh; P H Guth; M I Grossman
Journal:  Gastroenterology       Date:  1983-03       Impact factor: 22.682

8.  Resistance of germfree rats to indomethacin-induced intestinal lesions.

Authors:  A Robert; T Asano
Journal:  Prostaglandins       Date:  1977-08

9.  Isolation of Campylobacter pyloridis from human gastric mucosa and characterization of the isolates.

Authors:  T Itoh; Y Yanagawa; M Shingaki; M Takahashi; A Kai; M Ohashi; G Hamana
Journal:  Microbiol Immunol       Date:  1987       Impact factor: 1.955

10.  Campylobacter pyloridis, urease, hydrogen ion back diffusion, and gastric ulcers.

Authors:  S L Hazell; A Lee
Journal:  Lancet       Date:  1986-07-05       Impact factor: 79.321

View more
  8 in total

1.  Acute lethality of Helicobacter pylori in mice. A novel heat-labile toxin.

Authors:  H Inouye; T Mizuta; T Shimoyama; K Nagata; T Tanaka; T Tamura
Journal:  Gastroenterol Jpn       Date:  1991-04

2.  Restriction fragment length polymorphism of Helicobacter pylori using the urease gene probe.

Authors:  Y Tonokatsu; T Hayashi; T Mizuta; I Yamamoto; Y Fukuda; K Tamura; T Tamura; T Shimoyama
Journal:  Gastroenterol Jpn       Date:  1991-12

Review 3.  Helicobacter pylori.

Authors:  B E Dunn; H Cohen; M J Blaser
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

4.  Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells.

Authors:  K Nagata; H Satoh; T Iwahi; T Shimoyama; T Tamura
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

5.  Monoclonal antibodies against the native urease of Helicobacter pylori: synergistic inhibition of urease activity by monoclonal antibody combinations.

Authors:  K Nagata; T Mizuta; Y Tonokatu; Y Fukuda; H Okamura; T Hayashi; T Shimoyama; T Tamura
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

6.  A clinico-epidemiological analysis of Helicobacter pylori (H. pylori) by Southern blotting with A urease gene probe.

Authors:  Y Tonokatsu; T Hayashi; Y Fukuda; T Tamura; T Shimoyama
Journal:  J Gastroenterol       Date:  1994-04       Impact factor: 7.527

7.  Detection of serum IgG antibody against Helicobacter pylori from childhood in a Japanese population.

Authors:  N Matsukura; M Onda; A Tokunaga; T Teramoto; I Fujita; T Okuda; K Yamashita
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

8.  Topographic study of Helicobacter pylori and HLA-DR antigen expression on gastric epithelium.

Authors:  M Chiba; N Ishii; T Ishioka; M Murata; O Masamune; T Sugiyama; A Yachi
Journal:  J Gastroenterol       Date:  1995-04       Impact factor: 7.527

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.